Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View PlansCash Conversion
1.70x
KOLTEPATIL's operating cash flow exceeded net income in FY 2025, indicating earnings are backed by actual cash generation.
Free Cash Flow
₹2.24B
KOLTEPATIL's free cash flow was ₹2.24B in FY 2025, up 245.6% from FY 2024.
Dividend Coverage
7.4x
KOLTEPATIL's free cash flow covered dividends 7.4x in FY 2025, leaving room for reinvestment or debt reduction.
CapEx Intensity
20.4%
Capital expenditure was 20.4% of operating cash flow in FY 2025 for KOLTEPATIL, indicating a capital-light business.
Hover the chart icon for YoY change.
| Item | Chart | 2024 | 2025 |
|---|---|---|---|
| Net Income | -611.10M | 1.66B | |
| Cash flow Operating Activities | -1.11B | 2.82B | |
| Investments in PPE | -431.20M | -574.60M | |
| Cash flow Investing Activities | -1.34B | -2.41B | |
| Dividend Paid | -304.00M | -304.00M | |
| Cash flow Financing Activities | 3.19B | -1.60B | |
| Cash at beginning of period | 2.26B | 3.00B | |
| Cash at end of period | 3.00B | 1.80B | |
| Free Cash Flow | -1.54B | 2.24B |
Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025